Press Releases

Media Focus

The MC roundtable: how CDMOs are responding to pharma’s top priorities in 2021 (part II)

The MC roundtable: How CDMOs are responding to pharma’s top priorities in 2021 (part 2) At Samsung Biologics, we've worked hard to adapt and automate our processes, which then allows our customers to benefit from these improved efficiencies. READ MORE

In part two of Manufacturing Chemist's virtual roundtable, James Choi, our SVP, Chief Information & Marketing Officer, and Head of Investor Relations, and representatives from a number of top-tier CMOs and CDMOs, discussed how we're approaching speed-to-market through the adoption of automation strategies that accelerate the pace of process development. 

 

Read more

 

All rights are reserved by the media that published this article. 

The MC roundtable: How CDMOs are responding to pharma’s top priorities in 2021 (part 2) At Samsung Biologics, we've worked hard to adapt and automate our processes, which then allows our customers to benefit from these improved efficiencies. READ MORE

In part two of Manufacturing Chemist's virtual roundtable, James Choi, our SVP, Chief Information & Marketing Officer, and Head of Investor Relations, and representatives from a number of top-tier CMOs and CDMOs, discussed how we're approaching speed-to-market through the adoption of automation strategies that accelerate the pace of process development. 

 

Read more

 

All rights are reserved by the media that published this article. 

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION